Recap: ADMA Biologics Q1 Earnings

ADMA Biologics ADMA reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

ADMA Biologics missed estimated earnings by 25.0%, reporting an EPS of $-0.1 versus an estimate of $-0.08.

Revenue was up $13.05 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 8.67% increase in the share price the next day.

Here's a look at ADMA Biologics's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.09 -0.14 -0.15 -0.17
EPS Actual -0.09 -0.13 -0.14 -0.16
Revenue Estimate 21.76M 18.72M 16.42M 14.58M
Revenue Actual 26.38M 20.68M 17.83M 16.05M

To track all earnings releases for ADMA Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!